Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10881689
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10883994
Identification of cancer stem cells markers and use of same for diagnosis and treatment
granted -
US 10874631
Altertoxin II as a selective inhibitor of Ewing family of tumor cells
granted -
US 10865387
Methods of obtaining pancreatic endocrine cells
granted -
US 10857184
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10857185
Compositions and methods for reprogramming non-neuronal cells into neuron-like cells
granted -
US 10849912
Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
granted -
US 10844353
Methods for preparing therapeutically active cells using microfluidics
granted -
US 10842826
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
granted -
US 10842823
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
granted -
US 10821078
Nanostructure enhanced targeting (NSET) of inflammatory cells
granted -
US 10821134
BK virus specific T cells
granted -
US 10821178
Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
granted -
US 10813952
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted -
US 10808230
Selection methods for genetically-modified T cells
granted -
US 10808225
Use of PDL1 expressing cells to convert T cells into regulatory T cells
granted -
US 10799584
Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents
granted -
US 10800833
Co-stimulatory domains for use in genetically-modified cells
granted -
US 10799461
Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
granted -
US 10765727
Compositions and methods for producing dendritic cells
granted -
US 10758526
Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways
granted -
US 10758613
Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells
granted -
US 10758614
Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase
granted -
US 10759863
Modulation of γδ T cells
granted